For over two decades, AllCells has been a leading provider of high-quality human primary blood and marrow-based cells.  Through experience and scientific expertise, AllCells maintains the best-in-class products and services with optimized protocols that ensure research and clinical-grade products are delivered on time to pharmaceutical, biotechnology, medical device, healthcare, and academic institutions around the world.
By consistently delivering high-viability, high-purity subtypes and guaranteeing an accurate cell count, AllCells has earned a reputation for high-quality cells with the ability to customize our product to meet even the most unique requirements.  AllCells – Quality Cells for Quality ScienceTM.
SOURCE Discovery Life Sciences

https://allcells.com/

AllCells

The world’s largest biospecimen inventory and procurement network with preeminent multi-omic service laboratories to accelerate precision medicine programs.

https://www.dls.com/

Discovery Life Sciences

Discovery Life SciencesTM (Discovery), the biospecimen and biomarker specialistsTM, today announced its acquisition of AllCells®, a leading provider of clinical-grade (GMP-compliant) and Research Use Only (RUO) primary cell products.  With more than 30 years of collective cell and gene therapy (CGT) experience, AllCells and Discovery will focus on providing revolutionary products and services with greater speed and reliability to satisfy the entire CGT continuum ─ from basic discovery through commercialization.

Discovery Life Sciences Acquires Allcells

Discovery Life Sciences Acquires Allcells

Company Info